HYALGAN

by Fidia Farmaceutici (Italy)

HYALGAN is a brand of sodium hyaluronate (HA) injections used to treat osteoarthritis (OA) of the knee. It was first launched in Europe in 1987 and was approved by the FDA in the United States in 1997. HYALGAN is manufactured by Fidia Farmaceutici, an Italian pharmaceutical company headquartered in Abano Terme, Italy.

HYALGAN is produced through a proprietary process that ensures high purity and efficacy. In 2011, Fidia regained full commercial rights to HYALGAN in the United States and began promoting, distributing, and selling the product through its subsidiary, Fidia Pharma USA Inc.

HYALGAN 2ml

HYALGAN 2ml

Syringe 1 x 2ml Pre-Filled 

Sodium Hyaluronate 20mg/2ml

HYALGAN 2ml is a viscosupplement containing 20mg of sodium hyaluronate per 2ml syringe. It is specifically designed for the treatment of knee osteoarthritis to relieve pain and improve joint mobility. Sodium hyaluronate is a natural substance found in the synovial fluid of joints. It acts as a lubricant and shock absorber, helping to restore the natural balance of the joint environment.

HYALGAN is administered through intra-articular injections. It is particularly effective for patients who have not responded adequately to other conservative treatments like physical therapy or oral pain medications.

IS YOUR PRODUCT MISSING FROM OUR RANGE?

Get in touch to hear more about how to become a supplier.

CONTACT US